Quality of reporting on randomized controlled trials on recurrent spontaneous abortion in China

Trials

Volumn 16, Issue 1, 2015, Pages

  Gao, Jie ^a   Deng, Gaopi ^a   Hu, Yunyun ^a   Huang, Yanxi ^a   Lu, Liming ^b   Huang, Dandan ^a   Li, Yadi ^a   Zhu, Lin ^a   Liu, Xiaojing ^a   Jin, Xin ^a   Luo, Songping ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

CONSORT statement; Quality of reporting; Randomized controlled trial; Recurrent spontaneous abortion

Indexed keywords

CHORIONIC GONADOTROPIN; PROGESTERONE;

ARTICLE; CHINA; CHINESE MEDICINE; FUNDING; HUMAN; IMMUNOTHERAPY; INTENTION TO TREAT ANALYSIS; PROTOCOL COMPLIANCE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT ABORTION; RECURRENT SPONTANEOUS ABORTION; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); ABORTION, HABITUAL; BIBLIOMETRICS; DOUBLE BLIND PROCEDURE; ECONOMICS; FEMALE; FINANCIAL MANAGEMENT; METHODOLOGY; PRACTICE GUIDELINE; PREGNANCY; QUALITY CONTROL; SAMPLE SIZE; SINGLE BLIND PROCEDURE; STANDARDS; WRITING;

ABORTION, HABITUAL; BIBLIOMETRICS; CHINA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; PERIODICALS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RESEARCH SUPPORT AS TOPIC; SAMPLE SIZE; SINGLE-BLIND METHOD; WRITING;

EID: 84928042027     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0665-6     Document Type: Article

References (30)

1. Pandey MK, Rani R, Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet. 2005;272(2):95-108.
2. Sugiura-Ogasawara M, Suzuki S, Ozaki Y, Katano K, Suzumori N, Kitaori T. Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness: the Okazaki Cohort Study in Japan. J Obstet Gynaecol Res. 2013;39(1):126-31.
3. Lin QD, Qiu LH. Pathogenesis, diagnosis, and treatment of recurrent spontaneous abortion with immune type. Front Med China. 2010;4(3):275-9.
4. Wen DI, Bei HZ. Research on the pathogenesis, diagnosis and treatment of female reproductive disorders. J Shanghai Jiaotong Univ (Medical Science). 2012;32(9):1161-5.
5. Yang GY, Luo H, Liao X, Liu JP. Chinese herbal medicine for the treatment of recurrent miscarriage: a systematic review of randomized clinical trials. BMC Complement Altern Med. 2013;13:320.
6. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2013;10:D3511.
7. Morley LC, Simpson N, Tang T. Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database Syst Rev. 2013;1:D8611.
8. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;10:D112.
9. Li JY, Zhang YF, Smith GS, Xue CJ, Luo YN, Chen WH, et al. Quality of reporting of randomized clinical trials in tai chi interventions-a systematic review. Evid Based Complement Alternat Med. 2011;2011:383245.
10. Pandis N, Shamseer L, Kokich VG, Fleming PS, Moher D. Active implementation strategy of CONSORT adherence by a dental specialty journal improved randomized clinical trial reporting. J Clin Epidemiol. 2014;67(9):1044-8.
11. Cui Q, Tian J, Song X, Yang K. Does the CONSORT checklist for abstracts improve the quality of reports of randomized controlled trials on clinical pathways? J Eval Clin Pract. 2014;20(6):827-33.
12. Xiao L, Hu J, Zhang L, Shang HC. Endorsement of CONSORT by Chinese medical journals: A survey of "instruction to authors". Chin J Integr Med. 2014;20(7):510-5.
13. Mbuagbaw L, Thabane M, Vanniyasingam T, BorgDebono V, Kosa S, Zhang S, et al. Improvement in the quality of abstracts in major clinical journals since CONSORT extension for abstracts: a systematic review. Contemp Clin Trials. 2014;38(2):245-50.
14. Blair DA, Hughes PJ, Woolley TJ. Pharmacy journal abstracts published in PubMed that abide by the CONsolidated Standards Of Reporting Trials (CONSORT) guidelines. J Med Libr Assoc. 2014;102(2):110-4.
15. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig. 2003;7(1):2-7.
16. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357(9263):1191-4.
17. Lai R, Chu R, Fraumeni M, Thabane L. Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol. 2006;24(7):1136-44.
18. Toulmonde M, Bellera C, Mathoulin-Pelissier S, Debled M, Bui B, Ilaliano A. Quality of randomized controlled trials reporting in the treatment of sarcomas. J Clin Oncol. 2011;29(9):1204-9.
19. Rios LP, Odueyungbo A, Moitri MO, Rahman MO, Thabane L. Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab. 2008;93(10):3810-6.
20. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319(7211):670-4.
21. Gluud LL, Thorlund K, Gluud C, Woods L, Harris R, Sterne JA. Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2008;149(3):219.
22. Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH. In the dark: the reporting of blinding status in randomized controlled trials. J Clin Epidemiol. 2002;55(8):787-90.
23. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272(2):125-8.
24. Pildal J, Hrobjartsson A, Jorgensen KJ, Hilden J, Altman DG, Gotzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol. 2007;36(4):847-57.
25. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336(7644):601-5.
26. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10(1):28-55.
27. Mcdonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7:9.
28. Chen X, Zhai X, Wang X, Su J, Li M. Methodological reporting quality of randomized controlled trials in three spine journals from 2010 to 2012. Eur Spine J. 2014;23(8):1606-11.
29. Kober T, Trelle S, Engert A. Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. J Natl Cancer Inst. 2006;98(9):620-5.
30. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet. 2005;365(9465):1159-62.